Monitoring biodistribution of glycoproteins with modified sugar chains

Biochimica et Biophysica Acta - General Subjects

Volumn 1622, Issue 3, 2003, Pages 179-191

  Takamatsu, Shinji ^a   Fukuta, Kazuhiro ^b   Asanagi, Mineko ^c   Abe, Reiko ^c   Yokomatsu, Tomoko ^c   Fujibayashi, Yasuhisa ^a   Makino, Tadashi ^c  

^a UNIVERSITY OF FUKUI   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c MITSUI CHEMICALS INC   (Japan)

Author keywords

Biodistribution; Fibroblast growth factor; Interferon ; Remodeling; Sugar chain

Indexed keywords

ASIALOGLYCOPROTEIN; ASIALOGLYCOPROTEIN RECEPTOR; FIBROBLAST GROWTH FACTOR; GALACTOSE; RECOMBINANT GAMMA INTERFERON; SUGAR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BLOOD; BONE TISSUE; BRAIN TISSUE; CARBOHYDRATE ANALYSIS; CONTROLLED STUDY; DRUG CLEARANCE; DRUG DISTRIBUTION; INTESTINE; KIDNEY PARENCHYMA; LIVER; MOUSE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; SIALYLATION; SPLEEN; STOMACH; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION;

CRICETINAE; CRICETULUS GRISEUS;

EID: 0041589448     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-4165(03)00141-7     Document Type: Article

References (47)

1. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology. 3:1993;97-130.
2. Kobata A. Structures and functions of the sugar chains of glycoproteins. Eur. J. Biochem. 209:1992;483-501.
3. Helenius A., Aebi M. Intracellular functions of N-linked glycans. Science. 291:2001;2364-2369.
4. Rudd P.M., Elliott T., Cresswell P., Wilson I.A., Dwek R.A. Glycosylation and the immune system. Science. 291:2001;2370-2376.
5. Takeuchi M., Inoue N., Strickland T.W., Kubota M., Wada M., Shimizu R., Hoshi S., Kozutsumi H., Takasaki S., Kobata A. Relationship between sugar chain structure and biological activity of recombinant human erythropoietin produced in Chinese hamster ovary cells. Proc. Natl. Acad. Sci. U. S. A. 86:1989;7819-7822.
6. Takeuchi M., Takasaki S., Shimada M., Kobata A. Role of sugar chains in the in vitro biological activity of human erythropoietin produced in recombinant Chinese hamster ovary cells. J. Biol. Chem. 265:1990;12127-12130.
7. Takeuchi M., Kobata A. Structures and functional roles of the sugar chains of human erythropoietins. Glycobiology. 1:1991;337-346.
8. Inoue N., Takeuchi M., Ohashi H., Suzuki T. The production of recombinant human erythropoietin. Biotechnol. Annu. Rev. 1:1995;297-313.
9. Oh-eda M., Hasegawa M., Hattori K., Kuboniwa H., Kojima T., Orita T., Tomonou K., Yamazaki T., Ochi N. O-linked sugar chain of human granulocyte colony-stimulating factor protects it against polymerization and denaturation allowing it to retain its biological activity. J. Biol. Chem. 265:1990;11432-11435.
10. Hoglund M. Glycosylated and non-glycosylated recombinant human granulocyte colony-stimulating factor (rhG-CSF) - what is the difference? Med. Oncol. 15:1998;229-233.
11. Inoue N., Watanabe T., Kutsukake T., Saitoh H., Tsumura H., Arai H., Takeuchi M. Asn-linked sugar chain structures of recombinant human thrombopoietin produced in Chinese hamster ovary cells. Glycoconj. J. 16:1999;707-718.
12. Conradt H.S., Egge H., Peter-Katalinic J., Reiser W., Siklosi T., Schaper K. Structure of the carbohydrate moiety of human interferon-β secreted by a recombinant Chinese hamster ovary cell line. J. Biol. Chem. 262:1987;14600-14605.
13. Kagawa Y., Takasaki S., Utsumi J., Hosoi K., Shimizu H., Kochibe N., Kobata A. Comparative study of the asparagine-linked sugar chains of natural human interferon-β1 and recombinant human interferon-β1 produced by three different mammalian cells. J. Biol. Chem. 263:1988;17508-17515.
14. Field M.C., Wainwright L.J. Molecular cloning of eukaryotic glycoprotein and glycolipid glycosyltransferases: a survey. Glycobiology. 5:1995;463-472.
15. Fukuda M., Bierhuizen M.F., Nakayama J. Expression cloning of glycosyltransferases. Glycobiology. 6:1996;683-689.
16. Fukuta K., Abe R., Yokomatsu T., Kono N., Asanagi M., Omae F., Minowa M.T., Takeuchi M., Makino T. Remodeling of sugar chain structures of human interferon-γ Glycobiology. 10:2000;421-430.
17. Fukuta K., Abe R., Yokomatsu T., Omae F., Asanagi M., Makino T. Control of bisecting GlcNAc addition to N-linked sugar chains. J. Biol. Chem. 275:2000;23456-23461.
18. Fukuta K., Abe R., Yokomatsu T., Minowa M.T., Takeuchi M., Asanagi M., Makino T. The widespread effect of β1,4-galactosyltransferase on N-glycan processing. Arch. Biochem. Biophys. 392:2001;79-86.
19. Fukuta K., Yokomatsu T., Abe R., Asanagi M., Makino T. Genetic engineering of CHO cells producing human interferon-γ by transfection of sialyltransferases. Glycoconj. J. 17:2000;895-904.
20. Yamamoto S., Hase S., Yamauchi H., Tanimoto T., Ikenaka T. Studies on the sugar chains of interferon-γ from human peripheral-blood lymphocytes. J. Biochem. (Tokyo). 105:1989;1034-1039.
21. Yamamoto S., Hase S., Fukuda S., Sano O., Ikenaka T. Structures of the sugar chains of interferon-γ produced by human myelomonocyte cell line HBL-38. J. Biochem. (Tokyo). 105:1989;547-555.
22. Pricer W.E., Ashwell G. The binding of desialylated glycoproteins by plasma membranes of rat liver. J. Biol. Chem. 246:1971;4825-4833.
23. Ashwell G., Harford J. Carbohydrate-specific receptors of the liver. Ann. Rev. Biochem. 51:1982;531-554.
24. Breitfeld P.P., Simmons C.F. Jr., Strous G.J., Geuze H.J., Schwartz A.L. Cell biology of the asialoglycoprotein receptor system: a model of receptor-mediated endocytosis. Int. Rev. Cyt. 97:1985;47-95.
25. Stockert R.J. The asialoglycoprotein receptor: relationships between structure, function, and expression. Physiol. Rev. 75:1995;591-609.
26. Lee Y.C., Lee R.T. Carbohydrate-protein interactions: basis of glycobiology. Acc. Chem. Res. 28:1995;321-327.
27. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
28. Yoneda A., Asada M., Suzuki M., Imamura T. Introduction of an N-glycosylation cassette into proteins at random sites: expression of neoglycosylated FGF. BioTechniques. 27:1999;576-590.
29. Kohase M., Kohno S., Yamazaki S., Shishido A., Kono R. Potency standardization of human interferon preparations for clinical trials. The Clinical Potential of Interferons. 1982;299-309 University of Tokyo Press, Japan.
30. Andoh S., Ohta T., Tanimoto T., Sano O., Yamauchi H., Ando O., Torigoe K., Kurimoto M. Natural human interferon-γ derived from lipopolysaccharide-stimulated human myelomonocytic HBL-38 cells. Jpn. J. Cancer Res. 79:1988;757-765.
31. Sareneva T., Pirhonen J., Cantell K., Kalkkinen N., Julkunen I. Role of N-glycosylation in the synthesis, dimerization and secretion of human interferon-γ Biochem. J. 303:1994;831-840.
32. Santell L., Ryll T., Etcheverry T., Santoris M., Dutina G., Wang A., Gunson J., Warner T.G. Aberrant metabolic sialylation of recombinant proteins expressed in Chinese hamster ovary cells in high productivity cultures. Biochem. Biophys. Res. Commun. 258:1999;132-137.
33. Drickamer K. Clearing up glycoprotein hormones. Cell. 67:1991;1029-1032.
34. Dini L., Autuori F., Lentini A., Oliverio S., Piacentini M. The clearance of apoptotic cells in the liver is mediated by the asialoglycoprotein receptor. FEBS Lett. 296:1992;174-178.
35. Windler E., Greeve J., Levkau B., Kolb-Bachofen V., Daerr W., Greten H. The human asialoglycoprotein receptor is a possible binding site for low-density lipoproteins and chylomicron remnants. Biochem. J. 276:1991;79-87.
36. Samlowski W.E., Spangrude G.J., Daynes R.A. Studies on the liver sequestration of lymphocytes bearing membrane-associated galactose-terminal glycoconjugates: reversal with agents that effectively compete for the asialoglycoprotein receptor. Cell. Immunol. 88:1984;309-322.
37. Ishibashi S., Hammer R.E., Herz J. Asialoglycoprotein receptor deficiency in mice lacking the minor receptor subunit. J. Biol. Chem. 269:1994;27803-27806.
38. Braun J.R., Willnow T.E., Ishibashi S., Ashwell G., Herz J. The major subunit of the asialoglycoprotein receptor is expressed on the hepatocellular surface in mice lacking the minor receptor subunit. J. Biol. Chem. 271:1996;21160-21166.
39. Lee Y.C., Townsend R.R., Hardy M.R., Lonngren J., Arnarp J., Haraldsson M., Lonn H. Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc lectin. Dependence on fine structural features. J. Biol. Chem. 258:1983;199-202.
40. Rice K.G., Weisz O.A., Barthel T., Lee R.T., Lee Y.C. Defined geometry of binding between triantennary glycopeptide and the asialoglycoprotein receptor of rat heptocytes. J. Biol. Chem. 265:1990;18429-18434.
41. Kronman C., Velan B., Marcus D., Ordentlich A., Reuveny S., Shafferman A. Involvement of oligomerization, N-glycosylation and sialylation in the clearance of cholinesterases from the circulation. Biochem. J. 311:1995;959-967.
42. Ogawara K., Nishikawa M., Takakura Y., Hashida M. Pharmacokinetic analysis of hepatic uptake of galactosylated bovine serum albumin in a perfused rat liver. J. Control. Release. 50:1998;309-317.
43. Staud F., Nishikawa M., Takakura Y., Hashida M. Liver uptake and hepato-biliary transfer of galactosylated proteins in rats are determined by the extent of galactosylation. Biochim. Biophys. Acta. 1427:1999;183-192.
44. Andre S., Unverzagt C., Kojima S., Dong X., Fink C., Kayser K., Gabius H.-J. Neoglycoproteins with the synthetic complex biantennary nonasaccharide or its α2,3/α2,6-sialylated derivatives: their preparation, assessment of their ligand properties for purified lectins, for tumor cells in vitro, and in tissue sections, and their biodistribution in tumor-bearing mice. Bioconjug. Chem. 8:1997;845-855.
45. Unverzagt C., Andre S., Seifert J., Kojima S., Fink C., Srikrishna G., Freeze H., Kayser K., Gabius H.-J. Structure-activity profiles of complex biantennary glycans with core fucosylation and with/without additional α2,3/α2,6 sialylation: synthesis of neoglycoproteins and their properties in lectin assays, cell binding, and organ uptake. J. Med. Chem. 45:2002;478-491.
46. Connolly D.T., Townsend R.R., Kawaguchi K., Bell W.R., Lee Y.C. Binding and endocytosis of cluster glycosides by rabbit hepatocytes. Evidence for a short-circuit pathway that does not lead to degradation. J. Biol. Chem. 257:1982;939-945.
47. Regoeczi E., Chindemi P.A., Debanne M.T., Hatton M.W. Dual nature of the hepatic lectin pathway for human asialotransferrin type 3 in the rat. J. Biol. Chem. 257:1982;5431-5436.